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cytotoxicity in COS-1, HepG2 and 293T cells over the different weight ratios. The transfection efficiency 
of CS-ss-PEI4 was significantly higher than that of PEI 25k and comparable to Lipofectamine in 
mediating luciferase expression. Its application for BMP2 gene delivery was confirmed in C2C12 cells 
by BMP2 expression. For inducing in vitro osteogenic differentiation, CS-ss-PEI4 mediated BMP2 gene 
delivery showed stronger effect in MG-63 osteoblast cells and stem cells in terms of alkaline 
phosphatase (ALP) activity and mineralization compared with PEI25k and Lipofectamine. This study 
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Abstract 
Chitosan-disulfide-conjugated LMW-PEI (CS-ss-PEI) was designed to combine the 
biocompatibility of chitosan and the gene delivery ability of polyethylenimine (PEI) utilizing 
bio-reducible disulfide for bone morphogenetic protein (BMP2) gene delivery in mediating 
osteogenic differentiation. It was prepared by conjugating low molecular weight PEI (LMW-PEI) 
to chitosan through oxidization of thiols introduced for the formation of disulfide linkage. The 
structure, molecular weight and buffer capacity were characterized by Fourier transform infrared 
(FTIR), light scattering and acid-base titration respectively. The reduction of the molecular weight 
of CS-ss-PEI by reducing agent indicated its bio-reducible property. With the increment in 
LMW-PEI component, the copolymer showed increased DNA binding ability and formed denser 
nano-complexes. CS-ss-PEI exhibited low cytotoxicity in COS-1, HepG2 and 293T cells over the 
different weight ratios. The transfection efficiency of CS-ss-PEI4 was significantly higher than 
that of PEI 25k and comparable to Lipofectamine in mediating luciferase expression. Its 
application for BMP2 gene delivery was confirmed in C2C12 cells by BMP2 expression. For 
inducing in vitro osteogenic differentiation, CS-ss-PEI4 mediated BMP2 gene delivery showed 
stronger effect in MG-63 osteoblast cells and stem cells in terms of alkaline phosphatase (ALP) 
activity and mineralization compared with PEI25k and Lipofectamine. This study provides a 
potential gene delivery system for orthopaedic related disease.   
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1. Introduction 
     Gene therapy has received significant attention for its possible clinical application. By 
delivering therapeutic gene, it could show the advantages in the treatment of human genetic and 
acquired diseases over the conventional treatment.[1] However, the progress has been quite slow 
due to the difficulties in developing satisfactory gene carriers. Concerns regarding the immune and 
genetic toxicity of viral vectors have driven extensive attention to the development of nano-scale 
non-viral vectors. This kind of vector is superior in terms of simple usage, ease of producing, no 
specific immune response and high genetic material carrying capacity, whereas more effort is 
needed in improving its gene transfer ability.[2]  
Non-viral vectors could expand the application of gene therapy from cancer and monogenic 
diseases treatments to more prevalent disease such as orthopaedic disease.[3] Bone morphogenetic 
protein (BMP2) has been widely used for bone regeneration.[4] Gene therapy provides a 
promising way to sustainably express the BMP2 at the regeneration site, which could overcome 
the problems of protein treatment including short half-life, large dose requirement and high cost.[5] 
Furthermore, the property of transient gene expression possessed by non-viral vector is especially 
suitable for bone regeneration with the benefit in avoiding the adverse effect of BMP2 over 
expression.[6]  
Among the non-viral vectors, chitosan has been widely investigated for its excellent 
biocompatibility and biodegradability. Its low cytotoxicity has been demonstrated in experimental 
animals as well as clinical trials.[7] However, its application has been limited by its low 
transfection efficiency. Alternatively, polyethylenimine (PEI), known for the “proton sponge 
effect”, has been proven to be one of the most powerful and versatile members of non-viral vector 
both in vitro and in vivo.[8, 9] Nonetheless, the high cytotoxicity and the non-degradability 
hampered its clinical application. Although low molecular weight PEI (LMW-PEI) showed lower 
cytotoxicity, its transfection efficiency also decreased.[10] For developing satisfactory gene carrier, 
various modifications have been done to PEI and chitosan respectively. 
Taking into account the respective advantages of PEI and chitosan, their copolymer is 
expected to act as satisfactory gene carrier. Relevant studies showed that the copolymers of 
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chitosan and PEI (chitosan-g-PEI) exhibited enhanced transfection efficiency comparing to 
chitosan and improved biocompatibility relative to PEI.[11-14] Nonetheless, the non-degradable 
bonding in the copolymers may affect the further improvement of their properties.  
Disulfide bond with the property of reversible cross-linking has attracted extensive attentions 
recently. As it is reduction-sensitive, it could be cleaved by the high concentration of glutathione 
within the reductive intracellular environment.[15] This property could not only attenuate the 
overly condensation of DNA to facilitate DNA dissociating, but also further decrease the 
cytotoxicity.[16] Various biodegradable poly(disulfide amine)s containing repetitive disulfide 
bonds showed significantly increased transfection efficiency and decreased cytotoxicity.[17] 
Similarly, disulfide containing PEI derivatives constructed by LMW-PEI showed efficient gene 
transfection.[18-20] However, few studies could drive the goal of constructing biodegradable 
copolymer of chitosan and PEI utilizing disulfide linkage.[21] 
The aim of this study is to develop bio-reducible chitosan-disulfide-conjugated LMW-PEI 
(CS-ss-PEI) as novel non-viral vector and evaluate its efficiency. The optimal formula will be used 
to deliver BMP2 gene for osteogenic differentiation to provide a potential candidate for 
orthopaedic gene therapy. 
 
2. Materials and methods 
2.1. Materials 
Chitosan (CS, MW = 10 kDa) with 92% degree of deacetylation was supplied by AK Biotech 
Ltd. (Shandong, China). PEI (MW = 1.8 kDa and 25 kDa), dithiobis (2-nitrobenzoic acid) (DTNB) 
DL-Dithiothreitol (DTT) and 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide 
(MTT) were purchased from Sigma-Aldrich. N-Succinimidyl 3-(2-pyridyldithio)-propionate 
(SPDP) was provided by Thermo. PEI 25 kDa was purified by dialysis in deionized water and 
lyophilization before using for transfection. Lipofectamine
TM
 2000 was obtained from Invitrogen. 
Luciferase assay system and reporter lysis buffer were provided by Promega. BCA
TM
 protein 
assay kit was obtained from Thermo. Alizarin Red S, cetylpyridinium chloride (CPC) and 
Alkaline phosphatase yellow (pNPP) liquid substrate were got from Sigma. Phosphate-buffered 
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saline (PBS), ethylenediaminetetraacetate (EDTA)   sodium acetate (NaAc) and acetic acid 
(HAc) were obtained from Sigmal-Aldrich. Other chemicals were used directly without further 
purification. 
 
2.2.  Synthesis of CS-ss-PEI 
2.2.1. Synthesis of thiolated LMW-PEI and chitosan 
SPDP (2.5 mg) was firstly dissolved in DMSO, and then added to 1 mL PBS with EDTA 
buffer (PBS, 1mM EDTA, 0.02% sodium azide, pH 7). LMW-PEI (5 mg, 1.8 kDa) was dissolved 
in the reaction solution containing SPDP, and the reaction was performed at room temperature 
under stirring for 24 h to form thiolated LMW-PEI. The obtained product was purified by dialysis 
against deionized water (MW cutoff of 1000 Da) for 1 day to remove the unreacted SPDP.  
Thiolated chitosan was prepared with the similar procedure. Specifically, chitosan was firstly 
dissolved in 50 mM NaAc/HAc buffer, and then added to reaction solution containing SPDP with 
the final volume of 1 mL. After reaction with SPDP, the product was purified by dialysis (MW 
cutoff of 3500 Da) for 1 day.  
The thiolated degree was determined through monitoring the generation of 
pyridine-2-thione (PDP) groups at 343 nm (molar absorptivity=8080 cm
-1
M
-1
) upon the treatment 
of 20 mM DTT. Then the reduced products containing thiols were purified by dialysis in nitrogen 
atmosphere. The synthetic scheme was shown in Fig. 1A. 
2.2.2. Preparation of CS-ss-PEI  
Chitosan-disulfide-conjugated LMW-PEI (CS-ss-PEI) was prepared by oxidization of 
reduced thiols on PEI and chitosan at room temperature in the air to form disulfide linkage. 
Copolymers with different component were prepared at the different weight ratio (chitosan : 
LMW-PEI) of 2:1, 1:1, 0.5:1 and 0.25:1 (Table 1). The course of reaction was traced by 
monitoring the remaining content of free thiols using Ellman’s assay. Specifically, at each time 
point during the oxidation, a small amount of the reaction solution was incubated with dithiobis 
(2-nitrobenzoic acid) (DTNB, Ellman’s reagent) working solution for 15min at room temperature. 
Absorbance values were obtained on microplate reader at 405nm (Spectra Max 340), and thiol 
contents were determined using cysteine standards of known concentrations. The final products 
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were purified by dialysis (MW cutoff of 12 kDa) for 3 days.  
 
2.3. Characterization of CS-ss-PEIs 
The structure of CS-ss-PEIs was characterized by Fourier transform infrared (FTIR) 
spectroscopy on Perkin-Elmer spectrum BX FT-IR system. The molecular weight was estimated 
on static light scattering using Zetasizer Nano series by measuring the aqueous solution at 
different concentrations and calculated by Zimm Plot Software. The elemental compositions (C, N, 
O and S) of the copolymers were analyzed by energy dispersive X-ray spectrometer (EDS 
microanalysis, Oxford) equipped on the scanning electron microscopy (Hitachi S-3400N Variable 
Pressure SEM). 
The buffering capacity of CS-ss-PEIs was determined by acid-base titration. 1 mg of each 
sample was dissolved in 2 mL of deionized water and the pH value was initially adjusted to 11 by 
0.1 M NaOH. Then the pH value of solution was titrated to 3 by adding aliquots of 0.1 M HCl 
monitored by a microprocessor pH meter (PHM240).  
 
2.4  Characterization of CS-ss-PEI/DNA complexes 
2.4.1. Plasmid DNA preparation 
Plasmid used included pGL3-control (Promega) encoding luciferase, pEGFP-N1 (Clontech) 
encoding a red-shifted variant of wild-type green fluorescent protein (GFP) and pCI-neo-BMP2 
maintained in the lab encoding BMP2 gene. These plasmids were transformed into DH5α 
Escherichia coli, propagated in LB broth (Fluka) supplemented with 100 μg/mL ampicillin or 
kanamycin (Sigma), purified by Pure Yield
TM 
Plasmid Midiprep System (Promega), and stored in 
Tris-EDTA (TE) buffer (pH, 8) at -20
o
C respectively. The purity of plasmid DNA was determined 
to be above 1.8 by measuring the absorbance ratio of OD260/OD280 on ultraviolet (UV) 
spectrophotometer.  
2.4.2. Formation of CS-ss-PEI/DNA complexes 
The complexes of CS-ss-PEI and DNA were freshly prepared by mixing the equal volume of 
sterilized aqueous solution of copolymer and diluted DNA stock by deionized water. After briefly 
vortexing, the mixture was incubated for 30 min to allow the complexes formation. Various 
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weight ratios of complexes were reached by manipulating the concentration of copolymer to the 
same amount of DNA. 
2.4.3. Gel retardation of complexes    
The DNA condensation ability of CS-ss-PEIs was investigated by gel retardation. Agarose 
gel (1.0%) containing ethidium bromide (0.5 μg/mL) was prepared in Tris-Acetate-EDTA (TAE) 
buffer. Complexes solutions (8 μL) with various weight ratios were loaded into gels running at 90 
V for 20 min. Each well contained 0.1 μg of DNA. The results were visualized by irradiation 
under UV light. 
2.4.4. Transmission electron microscopy (TEM) 
The morphology of the complexes was observed by TEM (Philips Tecnai G2 20 S-TEM). 
One drop of each complex solution was carefully dropped on a clean copper grid and negatively 
stained by 1.5 wt.% phosphotungstic acid (pH 6.7). The samples were dried at room temperature 
before imaging. 
2.4.5. Particle size and zeta-potential 
The particle size and surface charge of CS-ss-PEI/DNA complexes were measured by 
Zetasizer Nano ZS instrument (MALVERN Instrument) in triplicates at 25 
o
C. The complexes 
containing 2 μg of DNA at various weight ratios (0.5:1–25:1) were diluted by deionized water to 1 
mL. The size was presented as the average value of five runs. 
 
2.5. Transfection efficiency and cytotoxicity 
2.5.1. Cell culture 
African green monkey kidney cells (COS-1), human kidney cells (293T) and human 
hepatoblastoma cells (HepG2) were cultured in Dulbecco’s Modified Eagles Medium (DMEM, 
GIBCO), supplemented with 10% fetal bovine serum (FBS, GIBCO) and 1% 
penicillin-streptomycin (Invitrogen) at 37
o
C in a humidified atmosphere. 
2.5.2. Transfection efficiency 
Cells were seeded in 24-well plate at an initial density of 6×10
4
 cell/well and allowed to 
reach 70%~80% confluence. Before transfection, the cells were washed with PBS and refreshed 
with antibiotics free medium. Then the cells were treated with complexes containing 1 μg of 
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pGL3-control plasmid at various weight ratios and incubated for 24 h. Before examination, cells 
were refreshed with complete medium and cultured for another 48 h. The transfection efficiency 
was evaluated by the expressed luciferase activity normalized by the protein content. The 
luciferase activity was determined by luciferase assay on the cell lysate using a microplate 
luminometer LB96v according to the manufacturer’s instruction. The protein content of the cell 
lysate was determined by BCA protein assay kit. All the experiments were carried out in triplicate. 
The GFP gene transfection was also conducted in 6-well plate with the similar procedure and 
observed under fluorescence microscopy.  
2.5.3. Cytotoxicity 
In vitro cytotoxicity of CS-ss-PEIs was evaluated by MTT assay. Cells were seeded in 
96-well plates at an initial density of 1×10
4
 cells/well and cultured in 100 μL medium containing 
cationic copolymers with different concentrations. The procedure was similar to the course of 
transfection for evaluating their cytotoxicity during transfection. The cytotoxicity of 
CS-ss-PEI/DNA complexes was also examined after transfection and at an early time point of 24h 
incubation. The MTT assay was performed according to the manufacturer’s instructions, and the 
results were showed as the percentage of cell viability. Each value was averaged from six 
independent experiments. 
 
2.6.  Osteogenic differentiation  
2.6.1. Cell culture 
C2C12 myoblast cells were maintained in DMEM supplemented with 10% FBS and 
antibiotics. MG63 osteoblast-like cells were maintained in α-minimal essential medium (α-MEM) 
with 10% FBS and antibiotics. Murine bone marrow stromal cells (BMSC) were collected by 
flushing bone marrow and cultured in α-MEM with 20% FBS and antibiotics. After 72 h of culture, 
non-adherent cells were removed by rinsing with PBS and adherent stromal cells were seeded into 
six-well plate at a density of 5.0×105 cells/well.[22] MSCs isolated from human umbilical cord 
(hUCB-MSC) were kindly donated by Chinese Eastern Union Stem cell & Gene Engineering 
Company and maintained in DMEM/F12 with 20% FBS and antibiotics.[23] 
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2.6.2. Osteogenic differentiation of skeletal cells 
Cells were transfected with pCI-neo-BMP2 by CS-ss-PEI and induced for osteogenic 
differentiation. For transfection, cells were seeded at 4×105 cells/well in six-well plate with the 
similar procedure to the reporter gene transfection. Then the cells were induced for osteogenic 
differentiation in α-MEM with 20 mM β-glycerol phosphate (Sigma), 1 nM dexamethasone 
(Sigma), and 0.5 μM ascorbate 2-phosphate (Sigma). The medium was changed every 2 days. 
    The expressed BMP2 mRNA and protein in C2C12 cells after transfection were examined by 
RT-PCR and Western blot. After extraction of total RNA by Trizol, RT-PCR was performed using 
High-Capacity cDNA reverse Transcription kit (Applied Biosystems) and Platinum PCR superMix 
High Fidelity (Invitrogen) according to the manufacturer’s instructions. In western blot analysis, 
the cell lysates were separated by SDS-PAGE and blotted onto a nitrocellulose membrane 
(Bio-Rad Laboratories). The proteins were analyzed with Anti Smad1 and 
Anti-phospho-Smad1/5/8 (Cell signaling) antibodies and visualized by SuperSignal West Femto 
Substrate system (Pierce). For osteogenic differentiation of osteoblast cells, the alkaline 
phosphatase (ALP) activity was stained by Sigma Fast BCIP/NBT Tablets (B5655) at the 10 days 
after transfection. The quantitative result of ALP activity was examined by determining 
p-nitrophenol content using ALP substrate solution (Sigma) normalized by total intracellular 
protein determined by BCA protein assay kit. Calcium mineralization of osteoblast and MSCs was 
stained by Alizarin Red S on 21 days of culture and quantitatively analyzed by destaining using 10% 
(w/v) cetylpyridinium chloride (CPC) on 550 nm absorbance. 
 
2.7.  Statistical analysis 
    All the data presented are expressed as mean ± SD. The statistical analysis was made using 
ANOVA and a multiple comparisons test. Normality and homogeneity of the variances were 
checked using the Shapiro-Wilk and Levene test before ANOVA. The difference was considered 
statistically significant when p value was less than 0.05. 
3. Results and discussion 
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3.1. Synthesis and characterization of CS-ss-PEI 
Chitosan-disulfide-conjugated LMW-PEI (CS-ss-PEI) was prepared utilizing SPDP 
heterobifunctional cross-linking reagent under mild condition. Firstly, SPDP was reacted with 
amine of chitosan or low molecular weight PEI (LMW-PEI) to prepare thiolated polymer 
respectively. Then, the reduced free thiol-containing LMW-PEI and chitosan underwent oxidation 
in air at room temperature to form disulfide bond with formation of the copolymer, as showed in 
Fig. 1A. Different copolymers were prepared by varying the molar ratio of chitosan to LMW-PEI. 
The proposed transfection mechanism of CS-ss-PEI mediated gene transfection was showed in Fig. 
1B with the intracellular reductive sensitivity. 
During the reaction, the thiolated degree was analyzed by the average number of thiols 
conjugated on every molecular chain utilizing the concentration of generated pyridine-2-thione 
(PDP). The results were 0.89, 1.74, 2.96 and 3.52 for four different thiolated chitosan as well as 
1.15 for the thiolated LMW-PEI respectively (Table 1). For chitosan, as the molar amount 
decreased in the reaction, the thiolation degree increased. Comparing with the initial feed ratio, the 
higher thiolation reaction rate could be found in PEI (38%) comparing with chitosan (22%~11%) 
as showed in table 1. This may be attributed to the higher amino density of PEI and less solubility 
of chitosan in the neutral reaction solution in terms of molecular chain. During the oxidation, the 
formed disulfide bonds were monitored using Ellman’s assay. As shown in Fig 2A, the remaining 
free thiols were expressed in the percentage of the initial concentration. The reaction rates were 
similar for the different copolymers, which may be attributed to the same amount of SPDP added 
in each system. After 4 days of oxidation, about 85% of the thiols were oxidized to form disulfide 
bonds. The average molecular weight of CS-ss-PEI was determined by static light scattering (SLS) 
(Table 1). It is an well-established analytical method and has been extensively used to determine 
the weight-average molecular weight of various polymers. CS-ss-PEI1 showed the largest 
molecular weight among the copolymers around 60 kDa and CS-ss-PEI4 showed the smallest one 
around 16 kDa. The molecular weight decreased with the increment of LMW-PEI component. 
When treated with DTT, the average molecular weight decreased because of the degradation of 
disulfide indicating its reducible property. 
The molecular structure of CS-ss-PEI was characterized by FTIR spectroscopy and 
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elemental analysis as shown in Fig. 2B and Table 2 respectively. In FTIR spectra, chitosan 
showed the representative bands at 1640 cm
-1
 and 1563 cm
-1
, which were attributed to C=O 
stretching (amide I band) and N-H deformation (amide II band). The band at 1077 cm
-1
 
corresponded to C-O stretching vibration.[24] PEI showed the characteristic peaks at 1660 cm
−1
 
for NH2 vibration and 1139 cm
-1
 for C-N stretching.[25] For CS-ss-PEI copolymers, with the 
increment of LMW-PEI component, there was an increase in the signal at around 1660 cm
-1
 
contributed by NH2 vibration. In addition, the signals at 1563 cm
-1 
for the amide II band and 1077 
cm
-1
 for C-O stretching decreased with reduction of chitosan component. Meanwhile, the 
appearance of the signals at 910 cm
-1
 and 840 cm
-1 
in the copolymers were corresponding to the 
C-S stretching vibration introduced by the SPDP cross-linking reaction.[26, 27] The elemental 
compositions (C, N, O and S) of chitosan and their copolymers were analyzed by the 
semi-quantitative SEM-EDS (Table 2). With the increment of PEI component in the copolymers, 
the mole fraction of oxygen atom brought by chitosan decreased. The fraction of nitrogen atom 
was correspondingly increase for its higher content in LMW-PEI than chitosan. Sulfur was 
introduced during the reaction, so it could only be found in the copolymers and showed increase 
with LMW-PEI component. The structure characterization confirmed the formation of CS-ss-PEI. 
The buffering effect polycations was assumed to facilitate the escaping of the complexes 
from endosomes. PEI is the most representative one and known for “proton sponge effect”. The 
buffering capacity of CS-ss-PEIs was investigated by the acid-base titration (Fig. 2C). Chitosan 
was not studied here because of the poor solubility in base solution. The buffering capacity of the 
CS-ss-PEIs increased with the component of the LMW-PEI contributed by its high amino density. 
The enlarged figure at the top right corner gave a clearer view of the titration curve in the range of 
pH 5.1-7.4 which is the pH change from the extracellular environment to the lower pH value of 
the endosomes. The buffering capacity of CS-ss-PEI4 is very close to that of PEI. 
 
3.2. Characterization of CS-ss-PEI/DNA complexes  
DNA condensation is one of the prerequisites for gene transfer. Examined by agarose gel 
electrophoresis, the migrations of DNA in agarose gel were completely retarded when the weight 
ratio was higher than 2:1 (polymer:DNA), indicating that all polymers could electrostatically 
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neutralize the plasmid DNA and deter electrophoretic mobility as shown in Fig. 3A. With the 
increment of LMW-PEI component, the critical complex ratio dropped to 1:1. This was attributed 
to the relative stronger DNA-binding ability of PEI when compared with chitosan. 
The surface properties of CS-ss-PEI/DNA complexes were investigated in morphology, 
particle size and zeta potential. Fig. 3B showed the representative morphology of complexes at 
weight ratio of 10 obtained by TEM. These complexes had spherical shape and compacted 
structure. The size of the complexes decreased with the increment of LMW-PEI component, 
corresponding to the gel retardation results.  
The particle size of complex is an important factor which influences cellular uptake. It has 
been reported that the typical size for cellular uptake ranges from 50 to several hundred 
nanometer.[28] As shown in Fig. 3C measured by SLS, above the weight ratio of 5:1 when the 
copolymer could completely condense DNA, the sizes of the complexes were less than 200nm. 
The relatively homogenous size distributions of complexes were unimodal as shown in Figure S1. 
The particle size of the complexes decreased with increasing weight ratio and approached a 
plateau around 100nm. Within the same weight ratio, it showed a decrease with the increment of 
LMW-PEI component, which was similar to the TEM results. The size of the complexes during 
transfection is influenced by many factors and the measurement in water is a limitation in this 
study. 
The complexes are formed upon self-assembly of negatively charged DNA with cationic 
polymer through electrostatic interaction, and the excessive cationic polymer contributes to the 
surface positive charge. This is necessary for the complexes binding to anionic cell surfaces for 
cellular internalization.[29] Fig. 3D showed the zeta potentials of the complexes at various weight 
ratios. At weight ratio 0.5, when the polymer could not completely condense DNA, the zeta 
potential of CS-ss-PEI/DNA complexes was almost negative except for CS-ss-PEI4. With the 
increase of weight ratio, the zeta potentials of the complexes rapidly increased to positive value 
and approached a plateau around 30 mV due to the saturation of polycations complexed with 
DNA. 
 
3.3. Cytotoxicity and transfection efficiency of CS-ss-PEI 
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     The cytotoxicity of CS-ss-PEI investigated by MTT assay was much lower than that of PEI 
and comparable to chitosan in COS-1 cells as shown in Fig. 4A. With the increment of LMW-PEI 
component, it showed slightly increase. The cytotoxicity of the complexes was even lower than 
that of polymer (Figure S2). This may be because part of the positive charge of polymer could be 
counterbalanced by the negative charge of DNA to minimize the direct contact with cell 
membrane.[30] Higher cell viability at earlier time point indicated that CS-ss-PEI mediated gene 
transfer does not have significant immediate toxicity as shown in Figure S3. Its cytotoxicity was 
also investigated with 293T and HepG2 cells. The highest cell viability of the copolymers was 
found in HepG2 cells. Although different cells showed different values, the tendency was similar 
to the situation of COS-1 cells as shown in Fig. 4B and 4C. PEI showed obvious cytotoxicity in 
the three kinds of cells. When the concentration of PEI was above 10 μg/mL, cells were barely 
alive. 
The gene transfer ability of CS-ss-PEI was investigated using the reporter genes of luciferase 
and GFP. Fig. 5A showed the gene transfection activity in COS-1 cell evaluated by luciferase 
assay. It could be observed that the gene expression increased with complex weight ratio and 
gradually leveled off. The optimum weight ratios for gene transfer were in the range of 15 to 25. 
CS-ss-PEI4 showed the highest transfection efficiency among the copolymers. At the weight ratios 
of 20 and 25, the gene transfection efficiency was superior to that of PEI and compatible to 
lipofectamine. The enhanced gene delivery ability was attributed to the incorporation of 
LMW-PEI component and increment of molecular weight, at the same time it may also include the 
contribution of bio-reducible disulfide bonding. It could be found that CS-ss-PEI3 and CS-ss-PEI4 
showed relatively higher gene delivery ability among CS-ss-PEI copolymers, so further evaluation 
on 293T and HepG2 cells for these two copolymers were performed (Fig. 5B, 5C). The results 
showed a similar trend. The transfection efficiency of CS-ss-PEI4 was higher than that of PEI both 
in 293T and HepG2 cells. In 293T cells, CS-ss-PEI4 showed 10-fold higher efficiency than that of 
PEI and even higher efficiency than that of Lipofectamine. For CS-ss-PEI3, it was similar to that 
of PEI. When applying the CS-ss-PEI4 for mediating GFP gene transfer, the clearly GFP 
expression could be observed in Fig. 5D  
Comparing the three cell lines, the transfection activity of the copolymers showed 
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dependence on cell lines, and the highest transfection activity was observed in COS-1 cells for 
both the copolymers and the control groups. CS-ss-PEIs showed significant enhancement in 
efficiency when compared with chitosan in all of the three cell lines, especially for CS-ss-PEI3 
and CS-ss-PEI4 with several hundred-fold increase. 
 
3.4. Osteogenic differentiation by BMP2 gene transfection 
     CS-ss-PEI4 had shown the optimal transfection efficiency among CS-ss-PEIs in mediating 
reporter gene delivery. Here it was applied to deliver BMP2 gene in vitro for osteogenic 
differentiation. Since BMP2 was mainly synthesized by skeletal cells, C2C12 myoblast cells were 
used for examining the expression of BMP2. The mRNA expression of BMP2 could only be 
observed in the group of BMP2 gene transfection 1 day post-transfection as shown in Fig. 6A. The 
control group and the GFP transfection group showed negative results. Similarly, apparent 
phosphorylation of Smad1/5/8 was observed in BMP2 gene transfection group 2 days 
post-transfection (Fig. 6B), indicated that the expressed BMP2 possesses the formal function. 
Smad1/5/8 is the well-known downstream signaling pathway of BMP2. BMPs exert their biologic 
effects via the Smad-independent signaling pathway during which Smad1/5/8 is phosphorylated 
and translocated into the nucleus.[31] These results confirmed the expression of BMP2 in C2C12 
cells after transfection mediated by CS-ss-PEI4. 
     Bone formation involves the differentiation of immature osteoblast and MSC. Transfection 
of MG-63 osteoblast cells with GPF gene by CS-ss-PEI4 could show clear GFP expression ( Fig. 
6C). By delivering BMP2 gene and osteoinduction, the enhanced osteogenesis could be observed 
on CS-ss-PEI4 group with darker red staining of Alizarin red at 21 days post-transfection 
comparing with the group of PEI and Lipofectamine (Fig. 6D). The quantification of 
mineralization was conducted by CPC extraction and the osteogenic effect showed in the order of 
CS-ss-PEI4 > PEI >Lipofectamine >control (Fig. 6E). This result suggested BMP2 gene delivered 
by CS-ss-PEI4 showed the stronger promoting effect in osteoblast differentiation and function.  
    The mesenchymal stem cell has the multiple differentiation capacity and could be induced 
osteogenic differentiation by BMP2. The osteogenic differentiation of BMSC was investigated 
through BMP2 gene transfection mediated by CS-ss-PEI4. Significant enhanced ALP activity in 
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transfection group could be observed both in the ALP staining (Fig. 6F) and in the quantitative 
assay (Fig. 6G) 10 days post-transfection. For the mineralization ability, there was clearly bone 
modules formed in transfection group stained by Alizarin Red with dark red which could not be 
found in the untransfected group (Fig. 6H). When applying this system to other kind of MSC, 
hUCB-MSC could also be induced for osteogenic differentiation which showed apparent calcium 
deposits in transfected group. 
 
4. Discussion 
Chitosan-disulfide-conjugated LMW-PEI (CS-ss-PEI) was synthesized by conjugating 
chitosan with low molecular weight PEI (LMW-PEI) utilizing disulfide. Different copolymers 
were prepared by tuning the amount of chitosan to the same amount of LMW-PEI. From 
CS-ss-PEI1 to CS-ss-PEI4, the component of chitosan decreased and LMW-PEI increased. Since 
chitosan has much higher molecular weight than LWM-PEI, the higher chitosan content resulted 
in higher molecular weight of the copolymer as indicated by the SLS results. During the 
preparation, SPDP was used for introducing the disulfide bond and maintained at the same molar 
ratio to LMW-PEI. As a result, the amount of disulfide in the copolymers increased with 
LMW-PEI component as shown by the results of elemental analysis. The increased disulfide did 
not contribute much to the molecular weight of the copolymer which was mainly affected by the 
chitosan component. However, the disulfide provided the copolymer with bioreducibility 
demonstrated by the reduced molecular weight after DTT treatment. The disulfide may also form 
between the molecular chain of chitosan or LMW-PEI themselves. This may contribute to the high 
molecular weight of CS-ss-PEI1 which possessed the highest chitosan component among the 
copolymers. However, the synthesized copolymers containing just chitosan or PEI content can 
hardly exist. Without PEI component, chitosan isn’t soluble in water which could be removed 
during the purification. With 1.15 average number of thiol group on every LMW-PEI molecular 
chain, it has low chance to form large-molecular weight PEI preserved during dialysis 
purification. 
The increased LMW-PEI component in the copolymer not only increased the buffer capacity, 
but also enhanced the DNA condensation ability. This influence is stronger than the one brought 
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by molecular weight. Plasmid DNA was complexed into denser nano-particles with lower critical 
complex ratio and smaller particle size. Before the endosomes matures, the gene carrier should be 
able to facilitate DNA escape, avoiding its degradation and inactivation.[32] It is widely accepted 
that the strong buffering capacity of PEI could successfully avoid its trafficking to acidic 
lysosomes, resulting in its high transfection efficiency.[33] The high density of nitrogen atom on 
its molecular backbone with the protonation potential gives it effective buffer capacity through a 
wide pH range.[34] However, the high charge density also results in the overly tight condensation 
of DNA which may affect the DNA dissociation and the cytotoxicity property.[35] The component 
of chitosan and reduction sensitive disulfide bond in CS-ss-PEI copolymer contributed to the high 
gene transfection efficiency of CS-ss-PEI4 in mediating reporter genes to different cells, which 
were even higher than that of PEI. The proposed mechanism of CS-ss-PEI mediated gene delivery 
was depicted in Fig. 1B. 
CS-ss-PEI was designed to balance the contributions of every component to maximize the 
collective effects on its gene transfer ability and biocompatibility. Although PEI is efficient in 
gene delivery, it usually showed high cytotoxicity with does- and molecular weight-dependent 
characteristic. It is mainly caused by its strong positive charge, which leads to strong electrostatic 
interaction with the plasma membrane and resulted in their damage.[36] Furthermore, PEI is a 
non-degradable polymer and will accumulate in the body leading to an unknown risk for 
long-term use. As shown in the results of the cytotoxicity, cells were barely alive in PEI group 
when its concentration was above 10 μg/mL. Since lower molecular weight PEI and chitosan 
showed relative low cytotoxicity, CS-ss-PEI showed good biocompatibility as expected. More 
than 80% of cell viability could be observed in three kinds of cells when the concentration of 
polymer reached 100 μg/mL. When forming the complexes with DNA, it showed even lower 
cytotoxicity. More effort in further improving its biocompatibility will be conducted for in vivo 
evaluation by turning the molecular weight and cross-linking degree. 
Efficient gene carrier is required to exhibit general significance in multiple cell types, which 
is also crucial for the extended therapeutic application in bone generation. This course involves 
the maturation of osteoblast for bone matrix synthesis and differentiation of mesenchymal stem 
cell into osteoblast lineage.[37] CS-ss-PEI4 was investigated in delivering BMP2 gene to multiple 
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cells for osteogenic differentiation. The BMP2 mRNA expression and the activated downstream 
signaling were observed in the transfected C2C12 myblasts cells as the confirmation of BMP2 
expression and function. Inducing osteogenic differentiation of mesenchymal stem cells and 
enhancing the function of the differentiated osteoblast is the fundamental function of BMPs.[38] 
In MG63 immature osteoblast cells, CS-ss-PEI4 group showed stronger effect in inducing 
mineralization comparing with PEI and Lipofectamine groups. The cytotoxicity of PEI did 
negatively affect its effect. The stronger osteogenic effect for CS-ss-PEI4 mediated BMP2 gene 
transfer compared with Lipofectamine may benefit from the PEI component, which has been 
reported to show much higher transfection level than any other non-viral vector in mammalian 
cells.[39] Apart from its “proton-sponge” effect, the superiority of PEI in these cells has also been 
suggested to associate with the different mechanism of cellular internalization of polyplexes 
comparing with lipoplexes.[40] The primary cells such as MSC are relative more difficult to 
transfect comparing with usually used transfected cell lines. It has been observed that most gene 
carriers work effectively for immortal cells but failed in transfecting primary cells[41]. Bone 
marrow stem cell (BMSC) and human umbilical cord blood mesenchymal stem cells (hUCB-MSC) 
isolated from mammalian were induced for osteogenic differentiation through BMP2 gene transfer 
mediated by CS-ss-PEI4 and showed significant stronger mineralization ability comparing with 
untransfected cells. More studies in osteogenic differentiation of MSC and in vivo bone 
regeneration should be performed to further elucidate the effects of CS-ss-PEI mediated gene 
delivery for osteogenesis in future study. 
 
5. Conclusions 
Chitosan-disulfide-conjugated LMW-PEI (CS-ss-PEI) CS-ss-PEI was prepared by grafting 
chitosan with low molecular weight PEI utilizing disulfide bond. This copolymer showed good 
DNA binding ability. The size of the complex inversely decreased with the weight ratio and PEI 
component which is around 100 nm. It exhibited low cytotoxicity in maintaining above 80% of 
cell viability in different cells. In delivering luciferase gene, CS-ss-PEI4 showed the highest 
transfection efficiency among the copolymers which is higher than PEI and comparable to 
Lipofectamine in COS-1, 293T and HepG2 cells. With respect to osteogenesis, this copolymer 
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medicated BMP2 gene delivery showed significant effect on osteogenic differentiation of 
osteoblast and mesenchymal stem cells in vitro. This novel non-viral gene transfer method shows 
great potential in gene therapy for treating orthopaedic disease. 
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Captions 
 
Figure 1. CS-ss-PEI preparation and gene delivery mechanism. (A) Reaction scheme for the 
preparation of CS-ss-PEI; (B) Proposed scheme for the mechanism of CS-ss-PEI 
mediated gene delivery. 
Figure 2. Characterization of CS-ss-PEI. (A) During the oxidation of free thiols to form 
disulfide bond, the reaction was traced by monitoring the remaining content of thiols 
using Ellman’s assay; (B) Structure characterization by FTIR spectra: with the increase 
of LMW-PEI component, the copolymer showed increase signal at around 1640 
cm
-1
( ), decreased signal at 1077 cm
-1
 (*) and appearance of the signal at 910 cm
-1
 
and 840 cm
-1
(☆); (C) Buffering capacity of the polymers by acid-base titration.  
Figure 3. Characterization of CS-ss-PEI/DNA complexes. (A) Gel retardation of complexes for 
their critical complex ratio, Lane 0, pDNA only; Lane 1-9, complex at weight ratio of 
polymer to pDNA=1:10, 1:6, 1:4, 1:1, 2:1, 4:1, 6:1, 10:1, scale bar: 500 nm; (B) TEM 
images of complexes at weight ratio of 10:1; (C) Particle size and (D) zeta-potential of 
complexes at various weight ratios ranging from 0.5:1 to 25:1.  
Figure 4. Cytotoxicity of copolymers at various concentrations in (A) COS-1, (B) 293T and (C) 
HepG2 cells by MTT assay. 
Fiture 5. Transfection efficiency of CS-ss-PEI in mediating luciferase gene delivery in (A) 
COS-1, (B) 293T and (C) HepG2 cells. (D) GFP expression in COS-1 cells transfected 
by pEGFP-N1 mediated by chitosan, CS-ss-PEI4, PEI and Lipofectamine. Scale bar, 
200 um.  
Figure 6. Application of CS-ss-PEI4 to BMP2 gene delivery for osteogenic differentiation. (A) 
BMP2 mRNA expression in C2C12 cells; (B) Activation of Smad1/5/8 as the 
downstream signaling pathway of BMP2 in C2C12 cells; (C) GFP expression in 
MG-63 osteoblast cells transfected by pEGFP-N1 mediated by CS-ss-PEI4, PEI and 
Lipofectamine. Scale bar, 200 um; (D) Mineralization of MG-63 stained by Alizarin 
Red S on 21 day, and (E) semi-quantificational analysis; (F) Alkaline phosphatase 
(ALP) activity in BMSC and (G) the quantitative analysis; (H) Mineralization of 
BMSC and hUCB-MSC stained by Alizarin Red S on 21 day. Scale bar, 100 um.  
 
Table 1. Preparation and characterization of CS-ss-PEI 
Table 2. SEM-EDS analysis of the elemental compositions (C, N, O and S) of chitosan and 
CS-ss-PEIs (n=3) 
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Figure  S1. Size distribution of complexes prepared at the weight ratio of 10. 
Figure  S2. Cytotoxicity of polymer/DNA complexes after transfection at weight ratios 5:1, 15:1 
and 25:1 corresponding to the polymer concentration of 10, 30 and 50 μg/mL.   
Figure  S3. Cytotoxicity of polymer/DNA complexes after 24h incubating with cells at weight 
ratios 5:1, 15:1 and 25:1 corresponding to the polymer concentration of 10, 30 and 
50 μg/mL.   
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Table 1.  
 
Samples Preparation 
 
Thiolation  Products  
DTT 
treat 
 
Feed 
(mg, nM) 
SPDP Feed 
(mg, nM) 
Feed 
rate 
Thiol1 
/Chain 
Thiolation 
rate (%)  
MW2  
(kDa) 
MW2  
(kDa) 
Chitosan-1 10,    1 1.25,  4 4 0.89 22 CsP1 59.5 50.0 
Chitosan-2 5,   0.5 1.25,  4 8 1.74 22 CsP2 19.75 16.8 
Chitosan-3 2.5,  0.25 1.25,  4 16 2.96 19 CsP3 17.2 12.5 
Chitosan-4 1.25, 0.125 1.25,  4 32 3.52 11 CsP4 16.6 8.6 
PEI 5,    2.8 2.5,   8 3 1.15 38 Chitosan 11.35 12 
1, The average number of thiol groups on every molecular chain is calculated by monitoring the generation of PDP 
group at 343 nm upon treatment of 20mM DTT (molar absorptivity=8080 cm-1M-1). 
2, Molecular weight determined by static light scattering. 
 
 
 
Table 2.  
 
Sample C mol% N mol% O mol% S mol% 
Chitosan 53.97±0.72 7.40±0.57 38.66±0.57 0.01±0.01 
CS-ss-PEI1 50.39±0.47 9.92±0.8 39.58±0.48 0.11±0.02 
CS-ss-PEI2 49.15±0.52 11.27±1.10 39.37±1.08 0.22±0.04 
CS-ss-PEI3 50.88±1.02 12.78±1.16 35.99±2.19 0.343±0.1 
CS-ss-PEI4 50.01±1.89 16.33±1.18 33.20±2.17 0.45±0.09 
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